The Effect of Myopia-Control Contact Lenses in New Zealand Chinese Children
Recruiting
Phase 3
Interventional Study
Myopia Progression
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 7 – 11
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 66 (estimated)
- Sponsor
- Aston University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study will employ a randomized, controlled, investigator-masked paired-eye comparison design to evaluate the effects of two myopia-control contact lenses-MiSight 1 Day and Abiliti 1-Day-in New Zealand Chinese children.
The study duration will be 6 months, with assessments conducted at baseline, 2 weeks, 3 months, and 6 months.
The clinical research will be conducted at the Auckland Myopia Cl…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Spherical refractive error between -1.00D and -4.50D
* Astigmatism of ≤1.00D
* No history of orthokeratology or atropine use
* No ocular diseases or surgical history
Exclusion Criteria:
o No ocular diseases or surgical history
Contacts